USC scientists have surmounted a big roadblock in regenerative medicine that has so far constrained the ability to use repurposed cells to treat diseases. The researchers figured out how to reprogram ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
Hot on the heels of his recent Nobel prize Dr John B. Gurdon has published today in BioMed Central’s open access journal Epigenetics & Chromatin research showing that histone H3.3 deposited by the ...
Morning Overview on MSN
AI is learning to decode diseases hidden in your DNA
Artificial intelligence is rapidly becoming medicine’s most powerful microscope, revealing patterns in human DNA that were ...
Resting brain stem cells hardly differ from normal astrocytes, which support the nerve cells in the brain. How can almost identical cells perform such different functions? The key lies in the ...
During the process of metastasis, tumor cells inevitably encounter the stimulation of various oxidative stressors, resulting in the fluctuation of intracellular reactive oxygen species (ROS) levels.
Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback